Developing vaccines and therapies for emerging infectious diseases
Official title: PROVIDENT: Prepositioning Optimized Strategies for Vaccines and Immunotherapeutics against Diverse Emerging Infectious Threats
Funded at Albert Einstein College of Medicine · NIH-10863592 · Data updated 2026-11-12
This study is working on new ways to create vaccines and treatments to help protect people from new viruses, and it's designed for anyone who wants better protection against infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | September 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $13,946,446 |
| NIH project number | 1U19AI181977-01 |
| Project ID | NIH-10863592 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of exposure to emerging infectious diseases caused by RNA viruses.
✕Less likely to help
Patients who are not at risk for these specific emerging infectious diseases may not receive any benefit from this research.
What this research studies
This research aims to create flexible vaccine and antibody strategies to combat new enveloped RNA viruses. It involves collaboration among multiple institutions to develop and test these strategies, focusing on understanding how these viruses infect hosts and how to effectively stimulate the immune response. The project will utilize advanced techniques in vaccine design and testing to ensure safety and efficacy, ultimately leading to products that can be quickly manufactured and approved for use. Patients may benefit from these innovations through improved protection against emerging infectious threats.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines and therapies that protect patients from serious emerging infectious diseases.
How similar studies have gone: Previous research has shown promise in developing vaccines and therapies for similar viral threats, indicating a potential for success in this approach.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Chandran, Kartik — Albert Einstein College of Medicine
- Study coordinator: Chandran, Kartik
Related research
Other NIH-funded projects on the same topics.
-
Participatory system dynamics to improve PrEP access in the Bronx
A community-driven project in the Bronx will use system dynamics to identify practical ways to help people at risk for HIV start and stay on PrEP.
-
Collaborative research network program for advancements in health science
A NIH-funded multi-institution project aims to advance health science through coordinated research efforts over five years for potential patient benefits.
-
Collaborative NIH Initiative to Advance Health
A national team project aims to make progress in a broad health area with potential benefits for patients.
-
A decentralized, post-incarceration program to help people living with or at risk for HIV
A patient-facing program called DEST2nation aims to help people recently released from jail or prison stay on HIV treatment (ART) and prevention (PrEP) by coordinating care, housing, and support services through peers and community organizations.
-
Project-002: a patient-facing look at a multi-institution effort
A concise, patient-friendly overview of a multi-site NIH project that may explore new approaches to health care over several years.
-
Plug-and-play vaccine and antibody blueprints for emerging flu-like viruses
A multi-team NIH grant aims to create adaptable vaccine and antibody blueprints to rapidly respond to new enveloped RNA viruses in three families.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.